EXHIBIT 31.1

                         CERTIFICATION UNDER SECTION 302
                        OF THE SARBANES-OXLEY ACT OF 2002


I, Michael Wilhelm, certify that:

1. I have  reviewed  this  quarterly  report on Form  10-QSB  of IR  BioSciences
Holdings, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this quarterly report.

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods represented in this report;

4. The   registrant's  other  certifying  officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rule 13a 15(e) and 15d-15(e)) and internal  controls over financial
reporting  (as defined in Exchange Act Rules  13a-15(f) and  15d-15(f))  for the
registrant and we have:

   a. designs such disclosure controls and procedures, or caused such disclosure
   controls and procedures to be designed under our supervision,  to ensure that
   material information  relating to the registrant,  including its consolidated
   subsidiaries,   is  made  known  to  us  by  others  within  those  entities,
   particularly during the period in which this report is being prepared;

   b. designed such internal  control over financial  reporting,  or caused such
   internal   control  over  financial   reporting  to  be  designed  under  our
   supervision,  to provide  reasonable  assurance  regarding the reliability of
   financial reporting and the preparation of financial  statements for external
   purposes in accordance with generally accepted accounting principles;

   c. evaluated the  effectiveness of the registrant's  disclosure  controls and
   procedures   and  presented  in  this  report  our   conclusions   about  the
   effectiveness of the disclosure controls and procedures, as of the end of the
   period covered by this report based on such evaluation; and

   d. disclosed in this report any change in the  registrant's  internal control
   over financial  reporting that occurred during the  registrant's  most recent
   fiscal  quarter that has  materially  affected,  or is  reasonably  likely to
   materially   affect,   the  registrant's   internal  control  over  financial
   reporting; and

5. The registrant's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

   a. all  significant  deficiencies  and material  weaknesses  in the design or
   operation of internal controls over financial  reporting which are reasonably
   likely to  adversely  affect the  registrant's  ability  to record,  process,
   summarize and report financial information; and

   b. any fraud,  whether or not  material,  that  involves  management or other
   employees who have a significant role in the registrant's  internal  controls
   over financial reporting.


/s/ Michael Wilhelm
------------------------
Michael Wilhelm
Chief Executive Officer
August 23, 2004